Progressive Multiple Sclerosis Transcriptome Deconvolution Indicates Increased M2 Macrophages in Inactive Lesions
- PMID: 32862178
- PMCID: PMC7572625
- DOI: 10.1159/000510075
Progressive Multiple Sclerosis Transcriptome Deconvolution Indicates Increased M2 Macrophages in Inactive Lesions
Abstract
Accumulating evidence suggests M2 macrophages contribute to tissue reparation and limit inflammation in multiple sclerosis (MS). However, most studies have focused on murine models without substantial support through human MS observations. The present study aimed to quantify the relative abundances of M2 macrophages in different lesion types excised from human MS patients. CIBERSORTx, an established RNA deconvolution algorithm, was applied on bulk RNA-sequencing data developed from 98 lesions from 10 progressive MS patients and 5 neuropathological control donors. A validated gene signature matrix for 22 human hematopoietic cell subsets was used to infer the relative proportions of immune cells that were present in the original lesion. Deconvolution of the bulk gene expression data showed that inactive lesions contained significantly more M2 macrophages compared to normal white matter control samples. The findings suggest that M2 macrophages may play a role during lesion inactivity in MS.
Keywords: Lesion; Macrophage; Multiple sclerosis; RNA-Sequencing.
© 2020 S. Karger AG, Basel.
Conflict of interest statement
Disclosure Statement
The author has no conflicts of interest to declare.
Figures
Similar articles
-
Molecular signature of slowly expanding lesions in progressive multiple sclerosis.Brain. 2020 Jul 1;143(7):2073-2088. doi: 10.1093/brain/awaa158. Brain. 2020. PMID: 32577755
-
Tissue-resident memory T cells invade the brain parenchyma in multiple sclerosis white matter lesions.Brain. 2020 Jun 1;143(6):1714-1730. doi: 10.1093/brain/awaa117. Brain. 2020. PMID: 32400866
-
Parenchymal accumulation of CD163+ macrophages/microglia in multiple sclerosis brains.J Neuroimmunol. 2011 Aug 15;237(1-2):73-9. doi: 10.1016/j.jneuroim.2011.06.006. Epub 2011 Jul 6. J Neuroimmunol. 2011. PMID: 21737148
-
Pathogenic Mechanisms Associated With Different Clinical Courses of Multiple Sclerosis.Front Immunol. 2019 Jan 10;9:3116. doi: 10.3389/fimmu.2018.03116. eCollection 2018. Front Immunol. 2019. PMID: 30687321 Free PMC article. Review.
-
Progressive multiple sclerosis.Semin Immunopathol. 2009 Nov;31(4):455-65. doi: 10.1007/s00281-009-0182-3. Semin Immunopathol. 2009. PMID: 19730864 Review.
Cited by
-
Integrative multi-omics and systems bioinformatics in translational neuroscience: A data mining perspective.J Pharm Anal. 2023 Aug;13(8):836-850. doi: 10.1016/j.jpha.2023.06.011. Epub 2023 Jun 30. J Pharm Anal. 2023. PMID: 37719197 Free PMC article. Review.
-
Cerebrospinal fluid cells immune landscape in multiple sclerosis.J Transl Med. 2021 Mar 25;19(1):125. doi: 10.1186/s12967-021-02804-7. J Transl Med. 2021. PMID: 33766068 Free PMC article.
-
Proteomic characterization of four subtypes of M2 macrophages derived from human THP-1 cells.J Zhejiang Univ Sci B. 2022 May 15;23(5):407-422. doi: 10.1631/jzus.B2100930. J Zhejiang Univ Sci B. 2022. PMID: 35557041 Free PMC article.
-
A Comprehensive Exploration of the Transcriptomic Landscape in Multiple Sclerosis: A Systematic Review.Int J Mol Sci. 2023 Jan 11;24(2):1448. doi: 10.3390/ijms24021448. Int J Mol Sci. 2023. PMID: 36674968 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources